SMOX and respiratory tract infectious disorder: In this study, we investigated the impact of AOs on the evolution of ciprofloxacin (CIP) resistance in <i>Pseudomonas aeruginosa</i> PAO1 using synthetic cystic fibrosis sputum medium (SCFM2), which mimics the physiochemical conditions of cystic fibrosis (CF) respiratory infections.